European Society of Human Reproduction and Embryology
Budget
€11,106,621
EP Access
0
accredited persons
Staff
3
0.95 FTE
EU Grants
None
Mission & Goals
The main aim of the European Society of Human Reproduction and Embryology is to promote interest in infertility care and to aim for a holistic understanding of reproductive biology and medicine. ESHRE collaborates with politicians and policy makers throughout Europe and world-wide, to serve as a primary source for evidence-based infertility care, and promotes inclusive legislation. For a full description of ESHRE's mission and values, please visit https://www.eshre.eu/Home/About-us/Mission-and-Vision
EU Legislative Interests
Regulation 2024/1938 on standards of quality and safety for substances of human origin intended for human application and repealing Directives 2002/98/EC and 2004/23/EC Regulation (EU) 2025/327 of the European Parliament and of the Council of 11 February 2025 on the European Health Data Space EU4Health and Horizon Europe programmes EU Roadmap for Women's Rights
Communication Activities
Events: - January 2018: Two-day conference about medically assisted reproduction organised at the Council of Europe - February 2018: ESHRE event with participation from the Council of Europe - November 2019: Roundtable co-organised with Fertility Europe in the European Parliament - November 2022: Roundtable event in the European Parliament on key considerations related to Medically Assisted Reproduction (MAR) on the EU SoHO Regulation Proposal - October 2024: Launch event of the Coalition for Fertility Position statements: - June 2021: ESHRE position paper on the revision of the European Union legislation on Blood Tissues and Cells - January 2022: Europe needs registries to protect the intended parents, third-party donors and children born from Medically Assisted Reproduction - May 2022: Responsible Innovation in Medically Assisted Reproduction - June 2022: Research and actions on infertility and Medically Assisted Reproduction: key topics to be considered for funding - October 2022: Healthcare stakeholders’ consensus response to the proposed European Health Data Space - January 2023: ESHRE position paper on the revised EU legislation on Substances of Human Origin - May 2023: ESHRE letter to MEPs about amendments to the SoHO regulation - June 2023: Enabling effective secondary use of health data in Europe: specific recommendations for a potential opt-out mechanism for the EHDS - November 2023: Reaction to the Council’s position on the SoHO Regulation - December 2023: Legislative refinement of the EHDS - February 2024: Concerns about the draft text of the EHDS Regulation in the trilogues - April 2024: Implementation of the EHDS - October 2024: ESHRE position paper on gamete donor compensation - March 2025: Stakeholder engagement and capacity building in the EHDS - March 2025: For a rights-based approach to fertility and demography - May 2025: Funding for health in the next EU budget - June 2025: For universal access to fertility treatments A full list of ESHRE's position statements can be accessed here: https://www.eshre.eu/Europe/Position-statements
Interests Represented
Does not represent commercial interests
Member Of
Biomedical Alliance in Europe (www.https://www.biomedeurope.org/) Coalition for Fertility (https://www.coalitionforfertility.eu/) Consortium Common Representation of Substances of Human Origin (CoRe SoHO) (https://europeanbloodalliance.eu/european-affairs/core-soho/)
Organisation Members
ESHRE does not have member organisations. ESHRE is an organisation with individual membership - see https://www.eshre.eu/Membership for more information. ESHRE has a partnership with the patient organisation Fertility Europe (http://fertilityeurope.eu).
Additional Information
Less than 1% of the total budget is spent on the activities covered by the Transparency Register. ESHRE is the coordinator of the EuMAR project (https://www.eshre.eu/Data-collection-and-research/EuMAR), which started in January 2023 and is co-funded by an EU4Health action grant. The maximum amount of EU funding granted for this project is 1,128,310.50 EUR over three years. In 2025, the project includes a task to develop policy recommendations, for which ca. 15,000 EUR of EU funding are allocated to staff costs.
Commissioner Meetings
No recorded meetings with EU commissioners.